ANDEMBRY 200 mg sol inj stylo autoinj
7680695530018
CH-69553
B06AC07
02.99.0.
Active substances:
1 / 3
google
Details
- GTIN
- 7680695530018
- Pharmacode
- -
- Product number
- 6955301
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigpen
- Composition
- garadacimabum 200 mg, histidinum, arginini hydrochloridum, prolinum 19.3 mg, polysorbatum 80 0.24 mg, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml.
Articles (1)
Andembry 200 mg, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
garadacimabum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
arginini hydrochloridum
|
- | Substance | HNIDK |
|
prolinum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 16158.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2025
Authorization holder
CSL Behring AG
3014 Bern
Authorization information
- Swissmedic authorization number
- 69553
- Drug name
- Andembry, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- B06AC07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/02/2025
- Authorization expiration date
- 23/02/2030
- IT number
- 02.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANDEMBRY 200 mg sol inj stylo autoinj
- Description (DE)
- ANDEMBRY 200 mg Inj Lsg AI
- Market launch
- 01/07/2025
- Narcotic (BTM)
- No